Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chiara Tognola has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cardiovascular Magnetic Resonance in MINOCA and Acute Myocarditis: A Comparative Multiparametric Evaluation

    by Chiara Tognola, Francesca Daus, Stefano Pedroli, Davide Bernasconi, Paola Sormani, Ilaria Bassi, Angela Milazzo, Giuseppina Quattrocchi, Cristina Giannattasio, Patrizia Pedrotti

    Myocardial infarction with non-obstructive coronary arteries (MINOCA) and acute myocarditis (AM) often present with overlapping clinical features and biomarker profiles, making early differential diagnosis challenging. Cardiovascular magnetic resonance (CMR) is the reference modality for etiological assessment through functional evaluation and multiparametric tissue characterization. The aim of this study was to compare clinical and CMR characteristics of patients with MINOCA and suspected AM, and to identify imaging features enabling accurate differentiation. We retrospectively analyzed 127 consecutive patients undergoing CMR (February 2021–October 2024): 62 with suspected MINOCA and 65 with suspected AM. Clinical data, laboratory findings, ECG, and CMR parameters (cine imaging, T1/T2 mapping, extracellular volume [ECV], and late gadolinium enhancement [LGE]) were assessed. MINOCA patients were older (median 59 years) and predominantly female (64.5%), whereas AM patients were younger (median 29 years) and mainly male (81.5%). AM was associated with higher troponin and inflammatory markers. Among patients initially referred with suspected MINOCA, LGE was present in 50.0%, compared with 93.8% of those referred with suspected acute myocarditis ( p < 0.001). MINOCA showed predominantly ischemic LGE patterns, while AM exhibited non-ischemic subepicardial or mid-wall LGE with myocardial edema. CMR confirmed myocardial infarction in 48.4% of patients and identified alternative diagnoses in 41.9%, while 9.7% had normal CMR findings. Multiparametric CMR reliably distinguishes ischemic from inflammatory myocardial injury in patients with chest pain, elevated troponin, and non-obstructive coronaries. Early CMR integration improves diagnostic accuracy and supports tailored management.

  • Open Access

    Beyond Coronary Stenosis: A Mechanism-Based Approach to Ischemic Heart Disease in Women

    by Chiara Tognola, Rita Cristina Myriam Intravaia, Giulia Colombo, Alberto Preda, Marisa Varrenti, Alessandro Maloberti, Patrizio Mazzone, Cristina Giannattasio, Fabrizio Guarracini

    Despite major advances in cardiovascular medicine, ischemic heart disease (IHD) in women remains underrecognized and undertreated. A substantial proportion of symptomatic women have no flow-limiting epicardial stenosis, and ischemia may arise from coronary microvascular dysfunction, vasospasm, diffuse atherosclerosis, plaque-related mechanisms, spontaneous coronary artery dissection (SCAD), or combinations of these processes. Female-specific biological factors—including hormonal transitions, vascular aging, inflammation, metabolic changes, and reproductive cardiovascular risk enhancers—modify the coronary substrate across the life course. This review integrates these determinants with contemporary coronary phenotyping and proposes a clinically oriented, mechanism-based framework for IHD in women. Multimodality imaging, invasive coronary functional testing, and intracoronary imaging are considered complementary tools for identifying predominant and coexisting mechanisms. Management should combine guideline-directed cardiovascular prevention with mechanism-targeted antianginal therapy and women-specific considerations, including reproductive planning, pregnancy counseling, medication safety, and psychosocial care. This framework is intended as a practical synthesis rather than a validated classification system and aims to support more precise diagnosis and individualized treatment of women with ischemic symptoms.

  • Open Access

    Cardiovascular Disease in Pregnancy: When Two Hearts Beat as One

    by Chiara Tognola, Filippo Brucato, Alessandro Maloberti, Marisa Varrenti, Alberto Preda, Patrizio Mazzone, Cristina Giannattasio, Fabrizio Guarracini

    Background: Cardiovascular disease (CVD) in pregnancy is a major cause of maternal morbidity and mortality, accounting for nearly one-third of pregnancy-related deaths worldwide. Physiological adaptations—expanded plasma volume, increased cardiac output, and a prothrombotic state—represent a natural cardiovascular stress test that may precipitate decompensation or unmask subclinical disease. Aim: This review critically examines contemporary evidence and international guidelines on the management of pregnancy-related cardiovascular disorders, focusing on pathophysiological mechanisms, diagnostic challenges, and therapeutic controversies. Content: The discussion centers on three high-impact clinical domains: (1) peripartum and preexisting cardiomyopathies, emphasizing mechanisms, prognosis, and the role of bromocriptine; (2) anticoagulation management in women with mechanical prosthetic valves, balancing maternal safety and fetal protection; and (3) hypertensive disorders of pregnancy, highlighting recent evidence from the CHAP and WILL trials and their implications for long-term cardiovascular prevention. Comparative analysis of ESC 2025 and AHA 2020 recommendations reveals broad consensus but persistent discrepancies in anticoagulation targets, postpartum surveillance, and follow-up strategies. Perspectives: Endothelial dysfunction, angiogenic imbalance, and systemic inflammation emerge as shared mechanisms linking diverse pregnancy-related cardiovascular conditions. Strengthening multidisciplinary care through Pregnancy Heart Teams, integrating obstetric and cardiologic expertise, and establishing structured postpartum follow-up pathways are essential to improve outcomes.


  • Open Access

    Idiopathic Ventricular Arrhythmias Originating from the Left Ventricular Summit: A Diagnostic and Therapeutic Challenge

    by Raffaele Falco, Chiara Tognola, Lorenzo Gigli, Matteo Baroni, Antonio Frontera, Marisa Varrenti, Alberto Preda, Marco Carbonaro, Roberto Menè, Leandro Fabrizio Milillo, et al.

    Premature ventricular contractions (PVCs) originating from the left ventricular summit (LVS) present a diagnostic and therapeutic challenge due to their complex anatomical location. The LVS includes an epicardial area of the left ventricle bordered by major coronary arteries, which has been increasingly recognized as an arrhythmic focus. Idiopathic ventricular arrhythmias from this area may exhibit specific electrocardiographic characteristics, making accurate localization essential for effective management. Methods: This narrative review explores the primary features of this arrhythmia, emphasizing key diagnostic and therapeutic aspects, including both pharmacological and interventional approaches, considering the recent technological advances in cardiac mapping and ablations. Conclusions: PVCs originating from the left ventricular summit (LVS) exhibit characteristic electrocardiographic features. Prompt recognition of this arrhythmia may facilitate appropriate referral for targeted treatment.


  • Open Access

    Advances in Hypertension Management: Insights from the Latest European Guidelines

    by Marco Zuin, Chiara Tognola, Alessandro Maloberti, Gianfranco Parati, Stefania Angela Di Fusco, Vered Gil Ad, Donatella Armata, Chiara Dalla Valle, Furio Colivicchi, Claudio Bilato, et al.

    Arterial hypertension is one of the most common and preventable risk factors for cardiovascular disease and its related mortality. Currently, the prevalence of hypertension in different European countries appears to be around 30–45% of the general population, with a steep increase with ageing. Recent European guidelines have introduced novel recommendations for the management and treatment of hypertensive patients, with direct implications in daily clinical practice. Therefore, in this focused review, we will provide answers to the most common questions regarding the diagnosis, management and treatment of arterial hypertension according to the latest available European guidelines.


  • Open Access

    Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Current Insights into Pathophysiology, Diagnosis, and Management

    by Chiara Tognola, Alessandro Maloberti, Marisa Varrenti, Patrizio Mazzone, Cristina Giannattasio, Fabrizio Guarracini

    Myocardial infarction with nonobstructive coronary arteries (MINOCA) is an increasingly recognized clinical entity characterized by myocardial injury in the absence of a significant coronary artery obstruction. MINOCA encompasses a diverse range of pathophysiological mechanisms, including coronary plaque disruption, coronary vasospasm, coronary microvascular dysfunction, thromboembolism, and spontaneous coronary artery dissection. A systematic diagnostic approach is essential to identify the underlying etiology and guide appropriate management strategies. Advanced imaging techniques, particularly cardiac magnetic resonance, play a pivotal role in distinguishing ischemic from non-ischemic myocardial injury and refining prognosis. Despite growing awareness, standardized treatment protocols remain limited, with current management largely extrapolated from strategies used in obstructive coronary artery disease. Notably, MINOCA is significantly more prevalent in women, emphasizing the need to understand sex-related differences in its pathophysiology, presentation, and clinical outcomes. This narrative review offers a comprehensive and up-to-date overview of MINOCA, including a dedicated chapter on sex-related considerations. It integrates recent advancements and highlights the importance of personalized management strategies.


  • Open Access

    Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Unveiling Sex-Specific Differences in Pathophysiology, Diagnosis, and Management

    by Chiara Tognola, Alessandro Maloberti, Marisa Varrenti, Patrizio Mazzone, Cristina Giannattasio, Fabrizio Guarracini

    Myocardial infarction with nonobstructive coronary arteries (MINOCA) is an increasingly recognized condition, with a higher incidence in women, characterized by myocardial injury without significant coronary artery obstruction. Sex-specific differences play a critical role in its pathophysiology, clinical presentation, and response to treatment. While the underlying mechanisms of MINOCA are diverse—including coronary microvascular dysfunction, coronary spasm, plaque rupture, coronary dissection, and thromboembolism—women are more frequently affected by non-atherosclerotic causes, particularly coronary microvascular dysfunction and spontaneous coronary dissection. Etiological investigations, including coronary angiography with intracoronary imaging, functional tests and physiology assessment, are crucial for identifying underlying causes, and advanced non-invasive techniques, such as cardiac magnetic resonance imaging, provide valuable insights. Current therapeutic strategies, including antiplatelet agents, beta-blockers, and statins, are largely extrapolated from studies in obstructive coronary artery disease, with limited evidence on their efficacy in MINOCA, particularly in women. This review explores sex-specific differences in the pathophysiology, diagnostic evaluation, and management of MINOCA, emphasizing the need for tailored approaches to improve outcomes.


  • Open Access

    Anderson–Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies

    by Chiara Tognola, Giacomo Ruzzenenti, Alessandro Maloberti, Marisa Varrenti, Patrizio Mazzone, Cristina Giannattasio, Fabrizio Guarracini

    Anderson–Fabry disease (AFD) is a rare X-linked lysosomal storage disorder characterized by the accumulation of globotriaosylceramide, leading to multi-organ involvement and significant morbidity. Cardiovascular manifestations, particularly arrhythmias, are common and pose a considerable risk to affected individuals. This overview examines current approaches to arrhythmic risk stratification in AFD, focusing on the identification, assessment, and management of cardiac arrhythmias associated with the disease. We explore advancements in diagnostic techniques, including echocardiography, cardiac MRI, and ambulatory ECG monitoring, to enhance the detection of arrhythmogenic substrate. Furthermore, we discuss the role of genetic and biochemical markers in predicting arrhythmic risk and the implications for personalized treatment strategies. Current therapeutic interventions, including enzyme replacement therapy and antiarrhythmic medications, are reviewed in the context of their efficacy and limitations. Finally, we highlight ongoing research and future directions with the aim of improving arrhythmic risk assessment and management in AFD. This overview underscores the need for a multidisciplinary approach to optimize care and outcomes for patients with AFD.


  • Open Access

    Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement

    by Chiara Tognola, Rita Cristina Myriam Intravaia, Eleonora Senini, Stefano Pezzoli, Alfonso Riccio, Elena Gualini, Saverio Fabbri, Valentina Bellantonio, Francesco Politi, Marta Campana, et al.


  • Open Access

    Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature

    by Eleonora Bonvicini, Alberto Preda, Chiara Tognola, Raffaele Falco, Roberto Gidiucci, Giulio Leo, Sara Vargiu, Marisa Varrenti, Lorenzo Gigli, Matteo Baroni, et al.

    Cardiac amyloidosis is the most frequent infiltrative disease caused by the deposition of misfolded proteins in the cardiac tissue, leading to heart failure, brady- and tachyarrhythmia and death. Conduction disorders, atrial fibrillation (AF) and ventricular arrhythmia (VA) significantly impact patient outcomes and demand recognition. However, several issues remain unresolved regarding early diagnosis and optimal management. Extreme bradycardia is the most common cause of arrhythmic death, while fast and sustained VAs can be found even in the early phases of the disease. Risk stratification and the prevention of sudden cardiac death are therefore to be considered in these patients, although the time for defibrillator implantation is still a subject of debate. Moreover, atrial impairment due to amyloid fibrils is associated with an increased risk of AF resistant to antiarrhythmic therapy, as well as recurrent thromboembolic events despite adequate anticoagulation. In the last few years, the aging of the population and progressive improvements in imaging methods have led to increases in the diagnosis of cardiac amyloidosis. Novel therapies have been developed to improve patients’ functional status, quality of life and mortality, without data regarding their effect on arrhythmia prevention. In this review, we consider the latest evidence regarding the arrhythmic risk stratification of cardiac amyloidosis, as well as the available therapeutic strategies.